Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases

Self/Nonself - Immune Recognition and Signaling

Volumn 1, Issue 3, 2010, Pages 225-230

  Derive, Marc ^a   Massin, Frédéric ^b   Gibot, Sébastien ^a,c  

^a INSERM   (France)

^b CHU NANCY BRABOIS   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Inflammation; Sepsis; TREM 1

Indexed keywords

HYBRID PROTEIN; LP 17; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PROTEIN KINASE SYK INHIBITOR; SYNTHETIC PEPTIDE; TOLL LIKE RECEPTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; CYSTIC FIBROSIS; DISEASE MODEL; HEMORRHAGIC SHOCK; HUMAN; INFLAMMATION; MELIOIDOSIS; NEOPLASM; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMONIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 78049279379     PISSN: 19382030     EISSN: 19382049     Source Type: Journal    
DOI: 10.4161/self.1.3.12891     Document Type: Review

References (73)

1. Diefenbach A, Raulet DH. Innate immune recognition by stimulatory immunoreceptors. Curr Opin Immunol 2003; 15:37-44.
2. Kubagawa H, Burrows PD, Cooper MD. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci USA 1997; 94:5261-6.
3. Cantoni C, Bottino C, Vitale M, et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med 1999; 189:787-96.
4. Dietrich J, Cella M, Seiffert M, Buhring HJ, Colonna M. Cutting edge: signal-regulatory protein β1 is a DAP12-associated activating receptor expressed on myeloid cells. J Immunol 2000; 164:9-12.
5. Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000; 164:4991-5.
6. Daws MR, Lanier LL, Seaman WE, Ryan JC. Cloning and characterization of a novel mouse myeloid DAP12- associated receptor family. Eur J Immunol 2001; 31:743-91.
7. Chung DH, Seaman WE, Daws MR. Characterization of TREM-3, an activating receptor on mouse macrophages: definition of a family of single Ig domain receptors on mouse chromosome 17. Eur J Immunol 2002; 32:59-66.
8. Bouchon A, Hernandez-Munain C, Cella M, Colonna M. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med 2001; 194:1111-22.
9. Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001; 410:1103-7.
10. Colonna M, Fachetti F. TREM-1: a new player in acute inflammatory responses. J Infect Dis 2003; 187:397-401.
11. Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, Colonna M, et al. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol 2003; 170:3812-8.
12. Radsak MP, Salih HR, Rammensee H, Schild H. Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol 2004; 172:4956-63.
13. Gibot S, Kolopp-Sarda MN, Béné MC, Bollaert PE, Lozniewski A, Mory F, et al. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 2004; 200:1419-26.
14. Lanier LL, Bakker AB. The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol Today 2000; 21:611-4.
15. Sharif O, Knapp S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 2008; 213:701-13.
16. Fortin CF, Lesur O, Fulop T. Effects of TREM-1 activation in human neutrophils: activation of signaling pathways, recruitment into lipid rafts and association with TLR4. Int Immunol 2007; 19:41-50.
17. Haselmayer P, Grosse-Hovest L, von Landenberg P, Schild H, Radsak MP. TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 2007; 110:1029-35.
18. McVicar DW, Taylor LS, Gosselin P, Willette-Brown J, Mikhael AI, Geahlen RL, et al. DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. J Biol Chem 1998; 273:32934-42.
19. Tessarz AS, Cerwenka A. The TREM-1/DAP12 pathway. Immunol Lett 2008; 116:111-6.
20. Hara H, Ishihara C, Takeuchi A, Imanishi T, Xue L, Morris SW, et al. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat Immunol 2007; 8:619-29.
21. Hara H, Saito T. CARD9 versus CARMA1 in innate and adaptive immunity. Trends in Immunology 2009; 30:234-42.
22. Dower K, Ellis DK, Saraf K, Jelinsky SA, Lin L. Innate immune responses to TREM-1 activation: overlap, divergence and positive and negative cross-talk with bacterial lipopolysaccharide. J Immunol 2008; 180:3520-34.
23. Ornatowska M, Azim AC, Wang X, Christman JW, Xiao L, Joo M, et al. Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. Am J Physiol Lung Cell Mol Physiol 2007; 293:1377-84.
24. Kelker MS, Foss TR, Peti W, Teyton L, Kelly JW, Wüthrich K, et al. Crystal structure of human triggering receptor expressed on myeloid cells 1 (TREM-1) at 1.47 A. J Mol Biol 2004; 342:1237-48.
25. Kelker MS, Debler EW, Wilson IA. Crystal structure of mouse triggering receptor expressed on myeloid cells 1 (TREM-1) at 1.76 A. J Mol Biol 2004; 344:1175-81.
26. Knapp S, Gibot S, de Vos A, Versteeg HH, Colonna M, van der Poll T, et al. Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J Immunol 2004; 173:7131-4.
27. Ramanathan B, Minton JE, Ross CR, Blecha F. Cloning of porcine triggering receptor expressed on myeloid cells-1 (TREM-1) and its induction by lipopolysaccharide, peptidoglycan and Salmonella enterica serovar Typhimurium infection. Dev Comp Immunol 2005; 29:1-7.
28. Gibot S, Massin F, Le Renard P, Béné MC, Faure GC, Bollaert PE, et al. Surface and soluble triggering receptor expressed on myeloid cells-1: expression patterns in murine sepsis. Crit Care Med 2005; 33:1787-93.
29. Zheng H, Heiderscheidt CA, Joo M, Gao X, Knezevic N, Mehta D, et al. MYD88-dependent and -independent activation of TREM-1 via specific TLR ligands. Eur J Immunol 2010; 40:162-71.
30. Zeng H, Ornatowska M, Joo MS, Sadikot RT. TREM- 1 expression in macrophages is regulated at transcriptional level by NFkappaB and PU.1. Eur J Immunol 2007; 37:2300-8.
31. Gómez-Piña V, Soares-Schanoski A, Rodríguez-Rojas A, Del Fresno C, García F, Vallejo-Cremades MT, et al. Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J Immunol 2007; 179:4065-73.
32. Wong-Baeza I, González-Roldán N, Ferat-Osorio E, Esquivel-Callejas N, Aduna-Vicente R, Arriaga-Pizano L, et al. Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients. Clin Exp Immunol 2006; 145:448-55.
33. Hamerman JA, Tchao NK, Lowell CA, Lanier LL. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol 2005; 6:579-86.
34. Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, Lanier LL, et al. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)- 2 and DAP12. J. Immunol 2006; 77:2051-2055.
35. Gibot S, Buonsanti C, Massin F, Romano M, Kolopp- Sarda MN, Benigni F, et al. Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock. Infect Immun 2006; 74:2823-30.
36. Gibot S, Alauzet C, Massin F, Sennoune N, Faure GC, Béné MC, et al. Modulation of the triggering receptor expressed on myeloid cells-1 pathway during pneumonia in rats. J Infect Dis 2006; 194:975-83.
37. Gibot S, Massin F, Marcou M, Taylor V, Stidwill R, Wilson P, et al. TREM-1 promotes survival during septic shock in mice. Eur J Immunol 2007; 37:456-66.
38. Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004; 350:451-8.
39. Wiersinga WJ, Veer CT, Wieland CW, Gibot S, Hooibrink B, Day NP, et al. Expression profile and function of triggering receptor expressed on myeloid cells-1 during melioidosis. J Infect Dis 2007; 196:1707-16.
40. Jarrar D, Chaudry IH, Wang P. Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches. Int J Mol Med 1999; 4:575-83.
41. Hierholzer C, Harbrecht B, Menezes JM, Kane J, MacMicking J, Nathan CF, et al. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 1998; 187:917-28.
42. Meng ZH, Dyer K, Billiar TR, Tweardy DJ. Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock. Am J Physiol Cell Physiol 2001; 280:343-51.
43. Meldrum DR, Shenkar R, Sheridan BC, Cain BS, Abraham E, Harken AH. Hemorrhage activates myocardial NFkappaB and increases TNFalpha in the heart. J Mol Cell Cardiol 1997; 29:2849-54.
44. Samy TS, Ayala A, Catania RA, Chaudry IH. Trauma-hemorrhage activates signal transduction pathways in mouse splenic T cells. Shock 1998; 9:443-50.
45. Shimizu T, Tani T, Endo Y, et al. Elevation of plasma peptidoglycan and peripheral blood neutrophil activation during hemorrhagic shock: plasma peptidoglycan reflects bacterial translocation and may affect neutrophil activation. Crit Care Med 2002; 30:77-82.
46. Shimizu T, Yu HP, Hsieh YC, Hanasawa K, Tsuchiya M, Kodama M. Flutamide Attenuates Pro-inflammatory Cytokine Production and Hepatic Injury Following Trauma-Hemorrhage via Estrogen Receptor-related Pathway. Ann Surg 2007; 245:297-304.
47. Macias CA, Chiao JW, Xiao J, Arora DS, Tyurina YY, Delude RL. Treatment with a novel hemigramicidin- TEMPO conjugate prolongs survival in a rat model of lethal hemorrhagic shock. Ann Surg 2007; 245:305-14.
48. Bini R, Olivero G, Trombetta A, Castagna E, Cotogni P. Effects of dimethyl sulfoxide, pyrrolidine dithiocarbamate and methylprednisolone on nuclear factor-kappaB and heat shock protein 70 in a rat model of hemorrhagic shock. J Trauma 2008; 64:1048-54.
49. Gibot S, Massin F, Alauzet C, Derive M, Montemont C, Collin S, et al. Effects of the TREM 1 pathway modulation during hemorrhagic shock in rats. Shock 2009; 32:633-7.
50. Oldenburg WA, Lau LL, Rodenberg TJ, Edmonds HJ, Burger CD. Acute mesenteric ischemia: a clinical review. Arch Intern Med 2004; 164:1054-62.
51. Victoni T, Coelho FR, Soares AL, de Freitas A, Secher T, Guabiraba R. Local and remote tissue injury upon intestinal ischemia and reperfusion depends on the TLR/MyD88 signaling pathway. Med Microbiol Immunol 2010; 199:35-42.
52. Suzuki T, Yamashita K, Jomen W, Ueki S, Aoyagi T, Fukai M, et al. The novel NFkappaB inhibitor, dehydroxymethylepoxyquinomicin, prevents local and remote organ injury following intestinal ischemia/ reperfusion in rats. J Surg Res 2008; 149:69-75.
53. Gibot S, Massin F, Alauzet C, Montemont C, Lozniewski A, Bollaert PE, et al. Effects of the TREM- 1 pathway modulation during mesenteric ischemia-reperfusion in rats. Crit Care Med 2008; 36:504-10.
54. Pamuk ON, Lapchak PH, Rani P, Pine P, Dalle Lucca JJ, Tsokos GC, et al. Spleen tyrosine kinase inhibition prevents tissue damage after ischemia reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2010; 299:G391-9.
55. Ferat-Osorio E, Wong-Baeza I, Esquivel-Callejas N, Figueroa-Figueroa S, Duarte-Rojo A, Guzmán- Valdivia-Gómez G, et al. Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitis. Crit Care 2009; 13:69.
56. Swaroop VS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA 2004; 291:2865-8.
57. Yasuda T, Takeyama Y, Ueda T, Shinzeki M, Sawa H, Takahiro N, et al. Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis. Crit Care Med 2008; 36:2048-53.
58. Wang D, Qin R, Liu Z, Gupta M, Chang Q. Expression of TREM-1 mRNA in acute pancreatitis. World J Gastroenterol 2004; 10:2744-6.
59. Kamei K, Yasuda T, Ueda T, Qiang F, Takeyama Y, Shiozaki H. Role of triggering receptor expressed on myeloid cells-1 in experimental severe acute pancreatitis. J Hepatobiliary Pancreat Sci 2010; 17:305-12.
60. Schenk M, Bouchon A, Seibold F, Mueller C. TREM- 1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. J Clin Invest 2007; 117:3097-106.
61. Park JJ, Cheon JH, Kim BY, Kim DH, Kim ES, Kim TI, et al. Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease. Dig Dis Sci 2009; 54:1525-31.
62. Kuai J, Gregory B, Hill A, Pittman DD, Feldman JL, Brown T, et al. TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines. Rheumatology (Oxford) 2009; 48:1352-8.
63. Collins CE, La DT, Yang HT, Massin F, Gibot S, Faure G, et al. Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis. Ann Rheum Dis 2009; 68:1768-74.
64. Murakami Y, Akahoshi T, Aoki N, Toyomoto M, Miyasaka N, Kohsaka H, et al. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis. Arthritis Rheum 2009; 60:1615-23.
65. Sharma SM, Choi D, Planck SR, Harrington CA, Austin CR, Lewis JA, et al. Insights in to the pathogenesis of axial spondyloarthropathy based on gene expression profiles. Arthritis Res Ther 2009; 11:168.
66. Ratjen FA. Cystic fibrosis: pathogenesis and future treatment strategies. Respir Care 2009; 54:595-605.
67. del Fresno C, Gómez-Piña V, Lores V, Soares-Schanoski A, Fernández-Ruiz I, Rojo B, et al. Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: downregulation of TREM-1 as putative underlying mechanism. PLoS ONE 2008; 3:2667.
68. del Fresno C, García-Rio F, Gómez-Piña V, Soares- Schanoski A, Fernández-Ruíz I, Jurado T, et al. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J Immunol 2009; 182:6494-507.
69. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860-7.
70. van Kempen LCL, de Visser KE, Coussens LM. Inflammation, proteases and cancer. Eur J Cancer 2006; 42:728-34.
71. Johansson M, Tan T, de Visser KE, Coussens LM. Immune cells as anti-cancer therapeutic targets and tools. J Cell Biochem 2007; 101:918-26.
72. Ho C, Liao WY, Wang CY, Lu YH, Huang HY, Chen HY, et al. TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer. Am J Respir Crit Care Med 2008; 177:763-70.
73. Matzinger P. Tolerance, danger and the extended family. Annu Rev Immunol 1994; 12:991-1045.